THE EFFECT OF MULTIDRUG RESISTANCE GENE EXPRESSION ON THE CLINICAL COURSE OF MULTIPLE MYELOMA

THE EFFECT OF MULTIDRUG RESISTANCE GENE EXPRESSION ON THE CLINICAL COURSE OF MULTIPLE MYELOMA

Background: Implementation of a proteasome inhibitor bortezomib into treatment of multiple myeloma has helped to improve survival of patients with this malignancy that is characterized by continuous relapsing course as a clinical manifestation of multidrug resistance (MDR). Previous studies have res...

Full description

Bibliographic Details
Main Authors: Yu. B. Chernykh, A. K. Golenkov, S. S. Shushanov, T. A. Kravtsova, E. Yu. Rybalkina, A. F. Karamysheva, T. A. Mitina, E. V. Trifonova, E. V. Kataeva, L. L. Vysotskaya, A. A. Stavrovskaya
Format: Article
Language:Russian
Published: MONIKI 2017-01-01
Series:Alʹmanah Kliničeskoj Mediciny
Subjects:
multiple myeloma
multidrug resistance
bortezomib-based regimen
Online Access:https://www.almclinmed.ru/jour/article/view/452

Similar Items

Similar Items